Unitary SPC should follow new patent system: EC official
11-06-2020
English appeals court overturns Regeneron transgenic mice decision
29-03-2018
Victor Moussa / Shutterstock.com
The UK Supreme Court today has sided with biopharmaceutical company Kymab, allowing its appeal in a suit involving Regeneron and patents covering transgenic mice.
You need a subscription to continue reading this content.
Start a subscription today to access the LSIPR website.
To access the full archive, digital magazines and special reports you will need to take out a paid subscription.
If you have already subscribed please login.
If you have any technical issues please email tech support.
For access to the complete website, archive, and to receive print publications, choose '12 MONTH SUBSCRIPTION'. For a free, two-week trial with full access, select ‘TWO WEEK FREE TRIAL’.
Kymab, Regeneron, UK Supreme Court, patent sufficiency, transgenic mice, patents, biotech
